Seer, Inc.
Business
Seer, Inc. develops and commercializes an integrated proteomics platform that enables unbiased, deep, rapid and scalable access to the proteome. Its core offering is the Proteograph Product Suite, comprising engineered nanoparticle consumables, the SP100 automation instrument, and the Proteograph Analysis Suite data software to generate peptide-level mass spectrometry-ready samples and analytical outputs. The company operates through product and service channels, including consumables, instrument sales/placements, cloud-based analysis, and fee-for-service access via Seer Technology Access Center and Centers of Excellence. Seer sells to academic, biopharmaceutical, biobank and translational research customers globally through direct sales, distributor and commercial partnerships.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 17 | 14 | 17 | 15 | 7 | |
| Total cost of revenue | 8 | 7 | 8 | 8 | 3 | |
| Gross profit | 8 | 7 | 9 | 7 | 3 | |
| Research and development | 44 | 51 | 53 | 46 | 29 | |
| Selling, general and administrative | 43 | 57 | 59 | 59 | 46 | |
| Total operating expenses | 86 | 107 | 112 | 104 | 75 | |
| Loss from operations | −78 | −100 | −103 | −97 | −71 | |
| Interest income | 12 | 17 | 18 | 5 | 326,000 | |
| Loss on equity method investment | −6 | −3 | 0 | — | — | |
| Other expense | −1 | −417,000 | −578,000 | −333,000 | 0 | |
| Total other income | 5 | 14 | 17 | 4 | 304,000 | |
| Loss before provision for income taxes | −73 | −87 | −86 | — | — | |
| Provision for income taxes | 201,000 | 98,000 | 0 | — | — | |
| Net loss | −74 | −87 | −86 | −93 | −71 | |
| Unrealized gain on available-for-sale securities | 323,000 | 328,000 | 1 | −715,000 | −590,000 | |
| Comprehensive loss | −73 | −86 | −85 | −94 | −72 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 47 | 41 | 32 | 53 | 233 | |
| Short-term investments | 139 | 196 | 284 | 368 | 167 | |
| Other receivables | 1 | 2 | 1 | 899,000 | — | |
| Inventory | 8 | 7 | 4 | 5 | 4 | |
| Prepaid expenses and other current assets | 2 | 3 | 3 | 2 | 3 | |
| Total current assets | 202 | 253 | 331 | 435 | 412 | |
| Long-term investments | 55 | 63 | 57 | 5 | 93 | |
| Operating lease right-of-use assets | 20 | 23 | 25 | 27 | 20 | |
| Property and equipment, net | 15 | 19 | 22 | 19 | 13 | |
| Restricted cash | 524,000 | 524,000 | 524,000 | 524,000 | 524,000 | |
| Other assets | 4 | 8 | 1 | 855,000 | 501,000 | |
| Total assets | 296 | 367 | 436 | 488 | 539 | |
| Accounts payable | 6 | 5 | 1 | 2 | 4 | |
| Accrued expenses | 7 | 8 | 9 | 8 | 8 | |
| Deferred revenue | 341,000 | 408,000 | 206,000 | 133,000 | — | |
| Operating lease liabilities, current | 3 | 2 | 2 | 2 | 864,000 | |
| Other current liabilities | 29,000 | 50,000 | 139,000 | 207,000 | 0 | |
| Total current liabilities | 16 | 15 | 13 | 13 | 13 | |
| Operating lease liabilities, net of current portion | 21 | 24 | 26 | 28 | 22 | |
| Other noncurrent liabilities | 8,000 | 48,000 | 179,000 | 320,000 | 341,000 | |
| Total liabilities | 37 | 39 | 39 | 41 | 36 | |
| Commitments and contingencies (Note 10) | — | — | — | — | — | |
| Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of December 31, 2025 and 2024; zero shares issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 725 | 720 | 703 | 668 | 630 | |
| Accumulated other comprehensive gain | 459,000 | 136,000 | −192,000 | −1 | −536,000 | |
| Accumulated deficit | −466 | −392 | −306 | −219 | −127 | |
| Total stockholders equity | 259 | 328 | 397 | 447 | 503 | |
| Total liabilities and stockholders equity | 296 | 367 | 436 | 488 | 539 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Stock-based compensation | 15 | 28 | 34 | 34 | 26 | |
| Depreciation and amortization | 6 | 6 | 6 | 4 | 3 | |
| Loss on disposal of property and equipment | 1 | 279,000 | 399,000 | 332,000 | 0 | |
| Net amortization of premium on available-for-sale securities | 1 | 3 | −12 | −833,000 | 1 | |
| Provision for inventory excess and obsolescence | 148,000 | 179,000 | 872,000 | 507,000 | 0 | |
| Non-cash operating lease expense | −9,000 | 91,000 | 211,000 | 2 | 1 | |
| Accounts receivable, net | 277,000 | 487,000 | 302,000 | −3 | −2 | |
| Prepaid expenses and other assets | 2 | −92,000 | −1 | −1 | −3 | |
| Inventory | −3 | −3 | −2 | −2 | −4 | |
| Accounts payable | 1 | 3 | −987,000 | −2 | 2 | |
| Deferred revenue | −67,000 | 202,000 | 73,000 | −243,000 | 126,000 | |
| Accrued liabilities and other liabilities | −520,000 | −1 | 1 | 251,000 | — | |
| Net cash used in operating activities | −44 | −46 | −59 | −61 | −46 | |
| Purchases of property and equipment | −2 | −4 | −7 | −10 | −7 | |
| Proceeds from disposal of property and equipment | 646,000 | 343,000 | 0 | 170,000 | 0 | |
| Purchases of available-for-sale securities | −173 | −263 | −403 | −366 | −280 | |
| Proceeds from maturities of available-for-sale securities | 238 | 342 | 445 | 254 | — | |
| Purchase of equity security | −2 | −10 | 0 | — | — | |
| Net cash provided by investing activities | 62 | 66 | 38 | −123 | −171 | |
| Proceeds from exercise of Class A common stock options | 56,000 | 0 | 97,000 | 3 | 2 | |
| Repurchases of Class A common stock under share repurchase program | −10 | −12 | 0 | — | — | |
| Taxes paid related to net settlement of restricted stock units | −827,000 | 0 | — | — | — | |
| Proceeds from issuance of Class A common stock in connection with employee stock purchase plan | 402,000 | 321,000 | 368,000 | 775,000 | 422,000 | |
| Net cash used in financing activities | −11 | −11 | 452,000 | 4 | 117 | |
| Net increase in cash, cash equivalents and restricted cash | 7 | 8 | −21 | −180 | −101 | |
| Cash paid for income taxes | 182,000 | 154,000 | 0 | 232,000 | 645,000 | |
| Capitalized stock-based compensation related to internal-use software development | 169,000 | 220,000 | 0 | — | — | |
| Property and equipment purchases included in accounts payable and accrued expenses | 131,000 | 248,000 | 415,000 | 354,000 | — | |
| Inventory transferred to property and equipment | 2 | 242,000 | 1 | 928,000 | 0 | |
| Property and equipment transferred to inventory | 62,000 | 699,000 | 121,000 | 327,000 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Seer, Inc.'s CIK number?
Seer, Inc.'s SEC CIK number is 0001726445 (1726445). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Seer, Inc.'s SEC filings?
All of Seer, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Seer, Inc. last report earnings?
Seer, Inc. (SEER) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-221696). This is Seer, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Seer, Inc.'s most recent earnings 8-K?
Seer, Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001193125-26-221696. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Seer, Inc.'s latest earnings 8-K →
Look up any company's CIK number →